全球榜 · 创新 Global · Innovation

全球创新指数Global Innovation Index

规模 + 质量 + 创新 + 贡献 四维自有算法 · 排名更新日期:2026-10-20Four-dimensional proprietary algorithm (Scale + Quality + Innovation + Contribution) · Last updated: 2026-10-20

综述Overview

Innovation is the primary driving force behind development and the core source of an economy's long-term competitiveness. In The Theory of Economic Development, Schumpeter defined innovation as "the establishment of a new production function"—a "new combination" of production factors and production conditions that brings qualitative change to economic growth; in The Competitive Advantage of Nations, Porter further pointed out that a nation's competitive advantage comes from sustained innovation and industrial upgrading, rather than the static comparative advantage of factor endowments.
创新是引领发展的第一动力,也是一个经济体长期竞争力的核心来源。熊彼特在《经济发展理论》中将创新定义为"建立一种新的生产函数"——把生产要素与生产条件进行"新组合",从而带来经济增长的质变;波特在《国家竞争优势》中进一步指出,国家的竞争优势来自持续的创新与产业升级,而非要素禀赋的静态比较优势。
Internationally, the World Intellectual Property Organization (WIPO) publishes the Global Innovation Index (GII), which evaluates more than a hundred economies worldwide using about 80 indicators. This index does not directly reproduce its rankings; instead, following the CPPPS principle of "computing from underlying public data," it selects cross-verifiable raw data—such as patents, R&D expenditure, papers, highly cited papers, technology enterprises, and industrialization—and independently designs the weights and computes the rankings.
国际上有世界知识产权组织(WIPO)发布的《全球创新指数》(GII),以约 80 项指标对全球上百个经济体进行评价。本指数不直接转载其名次,而是遵循 CPPPS"用底层公开数据自算"的原则,选取专利、研发经费、论文、高被引、科技企业、产业化等可交叉验证的原始数据,自行设计权重、自行计算排名。
This index constructs a four-dimensional framework of "Scale—Quality—Innovation—Contribution": Scale measures the total volume of innovation input and output; Quality measures the gold content of output (highly cited papers and patent quality); Innovation measures R&D intensity and the vitality of technology enterprises; Contribution (a distinctive CPPPS dimension generally absent from international rankings) measures the ability to industrialize and commercialize innovation outputs—this is precisely the key link in turning "innovation-driven development" and "new quality productive forces" into reality.
本指数构建"规模—质量—创新—贡献"四维框架:规模衡量创新投入与产出的总量;质量衡量产出的含金量(高被引、专利质量);创新衡量研发强度与科技企业活力;贡献(CPPPS 特色维度,国际榜单普遍缺失)衡量创新成果的产业化转化能力——这正是"创新驱动发展"与"新质生产力"落到实处的关键一环。
Evaluation results: China, the United States, South Korea, Germany, and Japan rank in the top five. Overall, leading economies with both scale and quality rank ahead; small Nordic and East Asian economies with high R&D intensity and superior patent quality rank toward the top; some economies with lower R&D intensity and weaker industrialization rank lower. The data for this ranking are mainly publicly known statistical approximations, uniformly marked "subject to official data," permanently free and public, and for research and reference only.
评价结果:中国、美国、韩国、德国、日本 位居前五。整体看,规模与质量兼备的头部经济体居前;研发强度高、专利质量优的北欧与东亚小型经济体名次靠前;部分研发强度偏低、产业化转化较弱的经济体靠后。本排名数据以公开统计近似值为主,一律标注"以官方为准",永久免费公开,仅供研究与参考。

分层梯队Tiers

A++ 前三Top 3 A+ 四至十4th–10th A 十一至二十11th–20th B 其余Rest

全球创新指数排名(30 个经济体)Global Innovation Index Ranking (30 economies)

排名国家/地区创新指数规模质量创新贡献研发强度%梯队
1中国China82.8396.677.763.6100.02.65A++
2美国United States82.591.894.478.867.73.5A++
3韩国South Korea66.2861.764.861.876.85.0A++
4德国Germany63.5258.578.746.273.23.1A+
5日本Japan60.3868.568.142.168.13.3A+
6以色列Israel60.3826.566.271.468.55.6A+
7英国United Kingdom56.7745.275.949.655.52.9A+
8瑞士Switzerland53.6129.274.338.770.33.3A+
9中国台湾Taiwan52.3438.957.938.274.43.8A+
10荷兰Netherlands51.1535.872.132.065.52.3A+
11法国France50.0542.765.635.557.92.2A
12瑞典Sweden49.3629.969.939.756.03.4A
13新加坡Singapore47.1620.961.933.569.82.2A
14加拿大Canada44.6242.465.428.445.01.7A
15比利时Belgium44.524.959.834.157.33.4A
16芬兰Finland42.819.761.333.853.63.0A
17丹麦Denmark42.7622.561.432.852.22.9A
18奥地利Austria42.2523.458.132.153.73.2A
19澳大利亚Australia40.7539.166.727.032.61.8A
20意大利Italy39.3835.659.220.545.31.5A
21爱尔兰Ireland36.8714.748.916.567.01.1B
22印度India36.8452.532.332.234.30.65B
23西班牙Spain35.7332.454.319.539.31.4B
24挪威Norway31.2418.047.319.040.51.9B
25波兰Poland26.7729.428.917.633.51.4B
26巴西Brazil25.1438.527.720.917.01.2B
27葡萄牙Portugal23.7514.736.417.026.41.7B
28俄罗斯Russia22.8440.324.99.922.41.0B
29新西兰New Zealand21.6811.139.613.921.51.4B
30冰岛Iceland18.470.028.018.723.42.5B

算法详细论述Methodology

一、评价依据

This algorithm does not presuppose a single definition of "innovation"; instead, it synthesizes multiple theoretical perspectives and maps them onto the four-dimensional framework:
本算法不预设单一"创新"定义,而是综合多元理论视角,映射到四维框架:
  1. 熊彼特《经济发展理论》:创新是"新组合"(新产品、新工艺、新市场、新原料、新组织),是经济发展的本质——为"创新维度"提供理论根基。
  2. 迈克尔·波特《国家竞争优势》:国家竞争力来自持续创新与产业升级——为"规模+质量"总量与含金量并重提供依据。
  3. OECD《弗拉斯卡蒂手册》:界定"研发(R&D)"与"研发强度(GERD/GDP)"的统计口径——为研发类指标提供统计规范。
  4. 创新驱动发展战略与新质生产力:强调"科技创新成果要转化为现实生产力"——为 CPPPS 特色"贡献(产业化)维度"提供本土思想依据。
  5. WIPO《全球创新指数》框架:以"创新投入—创新产出"两支柱衡量创新能力,本指数仅作方法论参照,不转载其名次。
  6. 中国《专利调查报告》专利产业化率:将"专利产业化"作为创新成果转化的核心观测指标——直接支撑"贡献"维度。

二、模型的数学结构

All indicators are first min-max standardized to [0,1]; the wide-ranging scale indicators (patents, R&D expenditure, papers, highly cited papers, technology enterprises, and high-tech exports) are log-transformed to avoid leading dominance. The four dimensions are then weighted and synthesized separately:
所有指标先极差标准化到 [0,1];规模类大跨度指标(专利、研发经费、论文、高被引、科技企业、高技术出口)取对数,避免头部垄断。四维分别加权合成:
规模 S = 0.40·log(专利) + 0.40·log(研发经费) + 0.20·log(论文) 质量 Q = 0.60·log(高被引) + 0.40·专利质量 创新 I = 0.50·研发强度 + 0.50·log(科技企业) 贡献 C = 0.50·产业化率 + 0.50·log(高技术出口) 创新指数 GII = 0.20·S + 0.25·Q + 0.30·I + 0.25·C
Among them, "Innovation" and "Contribution" together account for 55% of the weight, reflecting this index's emphasis on innovation vitality and the commercialization of results—innovation must not only be "able to produce" but also "able to land."
其中"创新"与"贡献"合计权重 55%,体现本指数对创新活力与成果转化的强调——创新不仅要"能产出",更要"能落地"。

三、指标与权重依据

指标方向维度权重依据
发明专利年申请量正向·对数规模 0.400.08创新产出总量(专利局统计)
研发经费总额正向·对数规模 0.400.08创新投入总量(弗拉斯卡蒂口径)
SCI 论文总量正向·对数规模 0.200.04基础研究产出总量
高被引论文正向·对数质量 0.600.15论文含金量(前1%)
专利质量指数正向质量 0.400.10三方/PCT占比与有效维持率
研发强度正向创新 0.500.15研发经费占 GDP 比重
科技企业(独角兽)正向·对数创新 0.500.15创新企业活力
创新成果产业化率正向贡献 0.500.125专利产业化/技术转化(CPPPS 特色)
高技术产品出口正向·对数贡献 0.500.125创新成果的国际转化能力

四、数据来源与局限性

R&D expenditure and R&D intensity refer to OECD/UNESCO statistical definitions; patent volume refers to national patent offices and WIPO PCT statistics; papers and highly cited papers refer to Web of Science/ESI and Scopus; technology enterprises refer to unicorn statistics agencies; the industrialization rate refers to China's Patent Survey Report and public research estimates. All of the above are publicly known approximations used for relative comparison in ranking, uniformly marked "subject to official data." This model does not include soft indicators such as the availability of venture capital, the institutional environment, and human capital; approximations may contain errors, and the ranking is for research and reference only.
研发经费、研发强度参考 OECD/UNESCO 统计口径;专利量参考各国专利局及世界知识产权组织 PCT 统计;论文与高被引参考 Web of Science/ESI 与 Scopus;科技企业参考独角兽统计机构;产业化率参考中国《专利调查报告》及公开研究估算。上述均为公开常识近似值,用于排名相对比较,一律标注"以官方为准"。本模型未纳入风险资本可得性、制度环境、人力资本等软性指标,且近似值存在误差,排名仅供研究与参考。

五、参考文献

  1. 熊彼特:《经济发展理论》(创新与"新组合"理论)。
  2. 迈克尔·波特:《国家竞争优势》。
  3. OECD:《弗拉斯卡蒂手册》(Frascati Manual,2015)。
  4. 世界知识产权组织(WIPO):《全球创新指数》(Global Innovation Index,方法参照,非名次转载)。
  5. UNESCO 统计研究所:研发经费与研发强度统计。
  6. 世界知识产权组织(WIPO):PCT 国际专利申请统计。
  7. Clarivate:Web of Science / ESI 高被引论文统计。
  8. 国家知识产权局:《中国专利调查报告》(专利产业化率)。
  9. 中国科学技术发展战略研究院:《国家创新指数报告》。

说明Notes

本版采用"规模 + 质量 + 创新 + 贡献"四维自有算法,不直接转载 WIPO《全球创新指数》名次,而以专利、研发经费、论文、高被引、科技企业、产业化等底层公开数据自行计算。规模类大跨度指标取对数,避免头部垄断;创新(研发强度+科技企业)与贡献(产业化率+高技术出口,CPPPS 特色)合计权重 55%,强调"创新要能落地"。数据为公开常识近似值,以官方为准;排名永久免费公开,永不卖榜。
This edition adopts the "scale + quality + innovation + contribution" four-dimension proprietary algorithm (not reproducing public list rankings): ① The scale dimension uses operating revenue with log₁₀ min-max standardization to avoid top-tier monopoly; ② The quality dimension equally weights net profit (losses truncated to 0) and total market cap; ③ The innovation dimension standardizes R&D investment with log₁₀; ④ The contribution dimension (CPPPS signature) counts self-developed innovative products (Class-1 new drugs/innovative biologics/original devices/innovative vaccines), stripping away the ranking inflation from generics, agency, and private-label products. Composite score = 0.20×scale + 0.30×quality + 0.25×innovation + 0.25×contribution. Data are public approximate values, subject to official figures. This ranking is permanently free and public, and rankings are never sold.